Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v31-v39.
Authors: P. Baas, D. Fennell, K. M. Kerr, P. E. Van Schil, R. L. Haas, S. Peters
Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour, although incidence has increased during the last ten years. The updated ESMO Clinical Practice Guidelines provide clear recommendations for management of this disease from diagnosis through treatment (medical, radiotherapy and surgery) to follow up.
